(6R,7R)-7-((R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid-D5; (6R,7R)-7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid-d5; 7-[D-?-Amino-(1,4-cyclohexadienyl)acetamide]-3-desacetoxycephalosphoranic Acid-d5; Anspor-d5; Cefradex-d5; Cefradin-d5; Cefradine-d5; Cefrag-d5; Cefro-d5; Celex-d5; Cephradinv; Cesporan-d5; Dimacef-d5; Easkacef-d5; Ecosporina-d5; Eskacef-d5; Lenzacef-d5; Lisacef-d5; Megacef-d5; SQ 11436-d5; Samedrin-d5; Sefril-d5; Velocef-d5; Velosef-d5
Cefradine-d5 is a fully characterized chemical compound used as a reference standard of API Cefradine. The standard offered is compliant with regulatory guidelines. Cefradine-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 38821-53-3 (non-d)